STE
STERIS·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
Ample Liquidity
High Cash/net Profit Ratio
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About STE
Steris Plc
A leading global provider of products and services that support patient care with an emphasis on infection prevention
Healthcare Equipment and Supplies
10/09/2014
03/28/2019
New York Stock Exchange
18,000
03-31
Common stock
70 Sir John Rogerson’s Quay, Dublin 2 , Ireland D02 R296
--
STERIS plc is a private limited liability company incorporated under the laws of England and Wales, established on October 9, 2014, to provide a range of professional outsourcing services to healthcare providers and other clients related to health management.
Earnings Call
Q4/2025
Estimate EPS2.6
Actual EPS2.74
Estimate Revenue1.47B
Actual Revenue1.48B
STERIS Q4 2025: Navigating Contradictions in Life Sciences Growth, Capital Orders, and M&A Strategy
May 21,2025 01:31
Earnings Decrypt
Earnings Decrypt
Q1/2026
Estimate EPS2.26
Actual EPS2.34
Estimate Revenue1.36B
Actual Revenue1.39B
STERIS plc's Q1 2026: Navigating Tariff Turbulence and Life Sciences Growth Challenges
Aug 07,2025 10:45
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
STE has released its 2026 Q2 earnings. EPS was reported at 2.47, versus the expected 2.35, beating expectations. The chart below visualizes how STE has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
STE has released its 2026 Q2 earnings report, with revenue of 1.46B, reflecting a YoY change of 9.89%, and net profit of 192.50M, showing a YoY change of 27.31%. The Sankey diagram below clearly presents STE's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
